Search fresh public links, source activity, and ready-to-use post angles for Breakthrough T1D.
Fresh curated links around Breakthrough T1D are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8...
A groundbreaking study unveiled at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting marks a pivotal advancement in the quest to develop curative therapi...
"The first drug that can delay the onset of type 1 diabetes is being made available on the NHS in England and Wales.Teplizumab is a form of immunotherapy that can give people thre...
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, peopl...
The autoimmunity associated with type 1 diabetes often begins in the first years of life, and the diagnosis of type 2 diabetes is rapidly rising among children and teens.
The National Institute for Health and Care Excellence (Nice) has approved teplizumab, with Diabetes UK saying it 'marks the start of a new age of treatment'.
UK research spend (2025): £1-15 million Type of impact: Knowledge creation (publications); tools and methods (research tools and databases); further funding. Summary: Pub...
Teplizumab is approved for children aged eight and over
Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’The world’s first drug to delay the onset...
The immunotherpay can give children and adults three extra years before they need to use insulin.
This brings real hope.ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
There are 1.5 million people in the U.S. living with type 1 diabetes (T1D). Nearly 200,000 of the people living with type 1 diabetes in the US are under the age of 20. What’s more,...
Биологи из Медицинского университета Южной Каролины (MUSC) совершили прорыв в эндокринологии, создав генетически модифицированные стволовые клетки, способные полностью остановить и...
In a groundbreaking advancement poised to deepen our understanding of diabetes and pancreatic function, a team of researchers has unveiled pivotal insights into the molecular regul...
For ten years, the Fr1da study, coordinated by Helmholtz Munich, has been investigating whether early stages of type 1 diabetes in children can be detected in routine pediatric car...
Doctors at Duke Health are using a cell-based implant to slow down the progression of MacTel, a rare retinal disease that damages light-sensitive cells in the back of the eye, caus...
Insulet, the diabetes device maker, debuted upgrades to its popular Omnipod 5 tubeless automated insulin delivery system.
Christopher Lieu, University of Colorado Anschutz/ The ConversationContinue ReadingCategory: Cancer, Illnesses and...
Hata hivyo, maendeleo ya hivi karibuni kutoka China yameibua matumaini kwamba siku moja baadhi ya wagonjwa wanaweza kuishi bila sindano hizo.
It has now been 15 months since the U.S. Preventive Services Task Force (USPSTF) last met. In the interim, several members' 4-year terms expired, and HHS Secretary RFK Jr. fired th...
Around six million people in the UK are thought to be living with type 2 diabetes, which occurs when the body does not produce enough insulin or cannot use it properly.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.